Biopharmaceuticals Contract Manufacturing Market to Grow at a CAGR of 8.2% to reach US$ 25,497.26 million from 2020 to 2027

Biopharmaceuticals Contract Manufacturing Market to 2027 - Global Analysis and Forecasts by Product (Biologics, Biosimilars); Service (Development Process, Final Dosage Operation, Analytical and Quality Control, Final Packaging), and Geography

Publication Month: Mar 2020 | Report Code: TIPRE00005512 | No. of Pages: 174 | Category: Biotechnology | Status: Published
Covid

The biopharmaceuticals contract manufacturing market was valued at US$ 13,727.13 million in 2019 and is expected to grow at a CAGR of 8.2% from 2020 to 2027 to reach US$ 25,497.26 million by 2027.

 

Biopharmaceuticals contract manufacturing refers to pharmaceutical companies outsourcing the development and manufacturing of drugs. CMOs have become a known name among pharmaceutical companies due to their cost effective services. The CMOs offer a wide range of services including research and development, analytical services and final dosage preparation and packaging. Moreover, growing biopharma industry is offering lucrative opportunities for the growth of the market. The growth of the Biopharmaceuticals Contract Manufacturing market is attributed to the some key driving factors such as increase demand of biologics, growing biosimilar pipeline, stringent regulation and increasing outsourcing activities. However, increasing competition in the industry is expected to restraint the growth of the market during the forecast years.

 

Lucrative Regional Biopharmaceuticals Contract Manufacturing Markets

Lucrative Regional Biopharmaceuticals Contract Manufacturing Markets

Get more information on this report :


 

 

Market Insights

Increasing Demand of Biologics

The contract manufacturing market for biologics is growing at an unprecedented rate owing to increasing biologics pipeline, manufacturing complexity, and companies shifting their focus towards core activities. Presently, many pharmaceutical and biotechnology companies outsource varied services from early-stage drug development to commercial-scale manufacturing. The outsourcing is required to expedite research and development, speed up market entry, give access to novel technologies, regulatory expertise, and reduces risks at a competitive cost. Complexities in biologics development and production and increasingly stringent quality standards have driven drug manufactures to prefer contract manufacturer services. Moreover, many companies are opting CMOs services to speed up the development process and lower production costs. For instance, in 2019, Dyadic International, Inc. agreed with Luina Bio Pty Ltd for the development and commercialization of its specific targeted antigen and biological products.

 

Product Insights

Based on product, biopharmaceuticals contract manufacturing market is segmented into biosimilar and biologics. The biologics segment held the largest share of the market in 2019 owing to increasing demand for biologics, increasing research, and development activities to develop new drugs for chronic indications in the forecast period. The market for biosimilar is expected to register the highest CAGR in the market during the forecast period due to patent expiration of blockbuster drugs and increasing pipeline.

 

Global Biopharmaceuticals Contract Manufacturing Market, by Product– 2019 & 2027

Global Biopharmaceuticals Contract Manufacturing Market, by Product– 2019 & 2027

Get more information on this report :


 

Service Insights

The biopharmaceuticals contract manufacturing market, by service, is segmented into development process, final dosage operations, analytical and quality control and final packaging. In 2019, the development process accounted for the largest market share in the global biopharmaceuticals contract manufacturing market owing to cutting edge technologies, risk becomes higher for small drug manufactures. However, analytical and quality control services are expected to grow at a significant CAGR in the forecast period owing to stringent regulatory regulation and complex manufacturing requirements of biologics.

 

Strategic Insights

 

Product launches and expansion strategy is commonly adopted by companies to expand their footprint worldwide and meet the growing demand. This strategy is most commonly adopted by the market players in order to expand its product portfolio.

The market players operating in the biopharmaceuticals contract manufacturing market adopted the strategy of product innovation to cater to changing customer demand across the world, which also permits the players to maintain their brand name globally.

 

Global Biopharmaceuticals Contract Manufacturing Market – By Product

  • Biologics
    • Monoclonal Antibodies
    • Recombinant Proteins
    • Vaccines
    • Others
  • Biosimilars

Global Biopharmaceuticals Contract Manufacturing Market – By Service

  • Development Process
  • Final Dosage Operation
  • Analytical and Quality Control
  • Final Packaging

Biopharmaceuticals Contract Manufacturing Market– By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

 

Company Profiles

  • Lonza Group AG
  • Boehringer Ingelheim International GmbH
  • Inno Biologics Ventures Sdn Bhd
  • Thermo Fisher Scientific
  • AbbVie Inc.
  • WuXi Biologics
  • General Electric
  • Samsung Biologics
  • Merck KGaA
  • Ajinomoto Co., Inc

 

1.             Introduction

1.1       Study Scope

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Biopharmaceutical Contract Manufacturing Market – By Product

1.3.2        Global Biopharmaceutical Contract Manufacturing Market – By Service

1.3.3        Global Biopharmaceutical Contract Manufacturing Market – By Geography

2.             Biopharmaceutical Contract Manufacturing Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Biopharmaceutical Contract Manufacturing – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America – PEST Analysis

4.2.2        Europe – PEST Analysis

4.2.3        Asia Pacific – PEST Analysis

4.2.4        Middle East and Africa (MEA) – PEST Analysis

4.2.5        South and Central America – PEST Analysis

4.3       Expert Opinion

5.             Biopharmaceuticals Contract Manufacturing Market – Industry Dynamics

5.1       Key Drivers

5.1.1        Increasing Outsourcing by Pharmaceutical Companies

5.1.2        Increasing Demand of Biologics

5.2       Key Market Restraints

5.2.1        Increasing Competition in the Industry

5.3       Key Market Opportunities

5.3.1        Emerging Markets

5.4       Future Trends

5.4.1        Consolidation in Pharmaceutical CMO Industry

5.5       Impact Analysis

6.             Biopharmaceutical Contract Manufacturing Market – Global Analysis

6.1       Global Biopharmaceutical Contract Manufacturing Market Revenue Forecast And Analysis

6.2       Global Biopharmaceutical Contract Manufacturing Market, By Geography - Forecast And Analysis

6.3       Market Positioning of Key Players

6.3.1        Lonza Group AG

6.3.2        Thermo Fisher Scientific, Inc.

7.             Biopharmaceuticals Contract Manufacturing Market Analysis – By Product

7.1       Overview

7.2       Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2019 and 2027)

7.3       Biologics

7.3.1        Overview

7.3.2        Biologics: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027  (US$ Million)

7.3.3        Monoclonal Antibodies

7.3.3.1      Overview

7.3.3.2      Monoclonal Antibodies: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)

7.3.4        Recombinant Proteins

7.3.4.1      Overview

7.3.4.2      Recombinant Proteins: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)

7.3.5        Vaccines

7.3.5.1      Overview

7.3.5.2      Vaccines: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)

7.3.6        Others

7.3.6.1      Overview

7.3.7        Others: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027  (US$ Million)

7.4       Biosimilars

7.4.1        Overview

7.4.2        Biosimilars: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027  (US$ Million)

8.             Biopharmaceuticals Contract Manufacturing Market – By Service

8.1       Overview

8.2       Biopharmaceuticals Contract Manufacturing Market, by Service, 2019 and 2027 (%)

8.3       Development Process

8.3.1        Overview

8.3.2        Development Process: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)

8.4       Final Dosage Operation

8.4.1        Overview

8.4.2        Final Dosage Operation: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)

8.5       Analytical and Quality Control

8.5.1        Overview

8.5.2        Analytical and Quality Control: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)

8.6       Final Packaging

8.6.1        Overview

8.6.2        Final Packaging: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)

9.             Biopharmaceutical Contract Manufacturing Market – Geographic Analysis

9.1       North America: Biopharmaceutical Contract Manufacturing Market

9.1.1        Overview

9.1.2        North America: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.1.3        North America: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027  (USD Million)

9.1.3.1      North America: Biologics Market, by Type, 2018–2027 (USD Million)

9.1.4        North America: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027  (USD Million)

9.1.5        North America: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)

9.1.6        US: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1      US: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2      US: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.1.6.2.1       US: Biologics Market, by Type, 2018–2027 (USD Million)

9.1.6.3      US: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.1.7        Canada: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027  (USD Million)

9.1.7.1      Canada: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2      Canada: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.1.7.2.1       Canada: Biologics Market, by Type, 2018–2027 (USD Million)

9.1.7.3      Canada: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.1.8        Mexico: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027  (USD Million)

9.1.8.1      Mexico: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2      Mexico: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.1.8.2.1       Mexico: Biologics Market, by Type, 2018–2027 (USD Million)

9.1.8.3      Mexico: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.2       Europe: Biopharmaceutical Contract Manufacturing Market

9.2.1        Overview

9.2.2        Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027  (USD Million)

9.2.3        Europe: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.2.3.1      Europe: Biologics Market, by Type, 2018–2027 (USD Million)

9.2.4        Europe: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.2.5        Europe: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)

9.2.6        Germany: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027  (USD Million)

9.2.6.1      Germany: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.2.6.2      Germany: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.2.6.2.1       Germany: Biologics Market, by Type, 2018–2027 (USD Million)

9.2.7        Germany: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.2.8        UK: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.2.8.1      UK: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.2.8.2      UK: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.2.8.2.1       UK: Biologics Market, by Type, 2018–2027 (USD Million)

9.2.8.3      UK: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.2.9        France: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027  (USD Million)

9.2.9.1      France: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.2.9.2      France: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.2.9.2.1       France: Biologics Market, by Type, 2018–2027 (USD Million)

9.2.9.3      France: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.2.10     Spain: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.2.10.1    Spain: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.2.10.2    Spain: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.2.10.2.1    Spain: Biologics Market, by Type, 2018–2027 (USD Million)

9.2.10.3    Spain: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.2.11     Italy: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.2.11.1    Italy: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.2.11.2    Italy: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.2.11.2.1    Italy: Biologics Market, by Type, 2018–2027 (USD Million)

9.2.11.3    Italy: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.3       Asia Pacific: Biopharmaceutical Contract Manufacturing Market

9.3.1        Overview

9.3.2        Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027  (USD Million)

9.3.3        Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.3.3.1      Asia Pacific: Biologics Market, by Type, 2018–2027 (USD Million)

9.3.4        Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.3.5        Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)

9.3.6        China: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.3.6.1      China: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.3.6.2      China: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.3.6.2.1       China: Biologics Market, by Type, 2018–2027 (USD Million)

9.3.6.3      China: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.3.7        Japan: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.3.7.1      Japan: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.3.7.2      Japan: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.3.7.2.1       Japan: Biologics Market, by Type, 2018–2027 (USD Million)

9.3.7.3      Japan: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.3.8        India: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.3.8.1      India: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.3.8.2      India: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.3.8.2.1       India: Biologics Market, by Type, 2018–2027 (USD Million)

9.3.8.3      India: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.3.9        South Korea: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.3.9.1      South Korea: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.3.9.2      South Korea: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.3.9.2.1       South Korea: Biologics Market, by Type, 2018–2027 (USD Million)

9.3.9.3      South Korea: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.3.10     Australia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.3.10.1    Australia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.3.10.2    Australia: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.3.10.2.1    Australia: Biologics Market, by Type, 2018–2027 (USD Million)

9.3.10.3    Australia: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.4       Middle East & Africa: Biopharmaceutical Contract Manufacturing Market

9.4.1        Overview

9.4.2        Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)

9.4.3        Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.4.3.1      Middle East & Africa: Biologics Market, by Type, 2018–2027 (USD Million)

9.4.4        Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.4.5        Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Share by Country – 2019 & 2027, (%)

9.4.6        Saudi Arabia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027  (USD Million)

9.4.6.1      Saudi Arabia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.4.6.2      Saudi Arabia: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.4.6.2.1       Saudi Arabia: Biologics Market, by Type, 2018–2027 (USD Million)

9.4.6.3      Saudi Arabia: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.4.7        UAE: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.4.7.1      UAE: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.4.7.2      UAE: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.4.7.2.1       UAE: Biologics Market, by Type, 2018–2027 (USD Million)

9.4.7.3      UAE: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.4.8        South Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027  (US$ Million)

9.4.8.1      South Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.4.8.2      South Africa: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.4.8.2.1       South Africa: Biologics Market, by Type, 2018–2027 (USD Million)

9.4.8.3      South Africa: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.5       South and Central America: Biopharmaceutical Contract Manufacturing Market

9.5.1        Overview

9.5.2        South and Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027  (US$ Million)

9.5.3        South and Central America: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.5.3.1      South and Central America: Biologics Market, by Type, 2018–2027 (USD Million)

9.5.4        South and Central America: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.5.5        South and Central America: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)

9.5.6        Brazil: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.5.6.1      Brazil: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.5.6.2      Brazil: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.5.6.2.1       Brazil: Biologics Market, by Type, 2018–2027 (USD Million)

9.5.6.3      Brazil: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.5.7        Argentina: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027  (USD Million)

9.5.7.1      Argentina: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.5.7.2      Argentina: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.5.7.2.1       Argentina: Biologics Market, by Type, 2018–2027 (USD Million)

9.5.7.3      Argentina: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

10.         Impact of COVID-19 Pandemic on Biopharmaceutical Contract Manufacturing Market

10.1    North America: Impact assessment of COVID-19 Pandemic

10.2    Europe: Impact assessment of COVID-19 Pandemic

10.3    Asia-Pacific: Impact assessment of COVID-19 Pandemic

10.4    Rest of World: Impact Assessment of COVID-19 Pandemic

11.         Biopharmaceutical Contract Manufacturing Market – Industry Landscape

11.1    Overview

11.2    Growth Strategies Done by the Companies in the Market, (%)

11.3    Organic Developments

11.3.1     Overview

11.4    Inorganic Developments

11.4.1     Overview

12.         Company Profiles

12.1    Boehringer Ingelheim International GmbH

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.2    THERMO FISHER SCIENTIFIC INC.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3    General Electric Company

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4    MERCK KGAA

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5    Lonza

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6    Samsung Biologics.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7    AbbVie Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8    WUXI BIOLOGICS

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9    Ajinomoto Co. Inc.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10 Inno Bio Ventures Sdn Bhd

12.10.1   Key Facts

12.10.2   Business Description

12.10.3   Products and Services

12.10.4   Financial Overview

12.10.5   SWOT Analysis

12.10.6   Key Developments

13.         Appendix

13.1    About The Insight Partners

13.2    Glossary of Terms

LIST OF TABLES

Table 1.             North America Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 2.             North America Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 3.             North America Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027 (USD Million)

Table 4.             US Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 5.             US Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             US Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027  (USD Million)

Table 7.             Canada Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 8.             Canada Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 9.             Canada Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027  (USD Million)

Table 10.          Mexico Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 11.          Mexico Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          Mexico Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027  (USD Million)

Table 13.          Europe Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 14.          Europe Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 15.          Europe Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027  (USD Million)

Table 16.          Germany Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 17.          Germany Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 18.          Germany Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027  (USD Million)

Table 19.          UK Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 20.          UK Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 21.          UK Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027  (USD Million)

Table 22.          France Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 23.          France Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 24.          France Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027  (USD Million)

Table 25.          Spain Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 26.          Spain Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 27.          Spain Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027  (USD Million)

Table 28.          Italy Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 29.          Italy Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 30.          Italy Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027 (USD Million)

Table 31.          Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 32.          Asia Pacific Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 33.          Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027 (USD Million)

Table 34.          China Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 35.          China Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 36.          China Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027  (USD Million)

Table 37.          Japan Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 38.          Japan Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 39.          Japan Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027 (USD Million)

Table 40.          India: R&D spending of Pharmaceutical companies (2010 & 2017)

Table 41.          India Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 42.          India Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 43.          India Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027  (USD Million)

Table 44.          South Korea Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 45.          South Korea Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 46.          South Korea Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027 (USD Million)

Table 47.          Australia Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 48.          Australia Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 49.          Australia Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027 (USD Million)

Table 50.          Middle East & Africa Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 51.          Middle East & Africa Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 52.          Middle East & Africa Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027 (USD Million)

Table 53.          Saudi Arabia Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 54.          Saudi Arabia Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 55.          Saudi Arabia Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027 (USD Million)

Table 56.          UAE Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 57.          UAE Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 58.          UAE Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027  (USD Million)

Table 59.          South Africa Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 60.          South Africa Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 61.          South Africa Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027 (USD Million)

Table 62.          South and Central America Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 63.          South and Central America Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 64.          South and Central America Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027 (USD Million)

Table 65.          Brazil Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 66.          Brazil Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 67.          Brazil Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027 (USD Million)

Table 68.          Argentina Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 69.          Argentina Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 70.          Argentina Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027 (USD Million)

Table 1.             Organic Developments Done By Companies

Table 2.             Inorganic Developments Done By Companies

Table 3.             Glossary of Terms, Biopharmaceutical Contract Manufacturing Market

 

 

LIST OF FIGURES

Figure 1.           Biopharmaceutical Contract Manufacturing Market Segmentation

Figure 2.           Biopharmaceutical Contract Manufacturing Segmentation, By Region

Figure 3.           Global Biopharmaceutical Contract Manufacturing Market Overview

Figure 4.           Biologics Segment Held Largest Share Of Product In Biopharmaceutical Contract Manufacturing Market

Figure 5.           Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Global Biopharmaceutical Contract Manufacturing Market, By Geography (US$ Million)

Figure 7.           Global Biopharmaceutical Contract Manufacturing Market- Leading Country Markets (US$ Million)

Figure 8.           Global Biopharmaceutical Contract Manufacturing Market, Industry Landscape

Figure 9.           North America PEST Analysis

Figure 10.        Europe PEST Analysis

Figure 11.        Asia pacific PEST Analysis

Figure 12.        Middle East and Africa (MEA) PEST Analysis

Figure 13.        South And Central America PEST Analysis

Figure 14.        Biopharmaceutical Contract Manufacturing Market Impact Analysis of Drivers and Restraints

Figure 15.        Global Biopharmaceutical Contract Manufacturing Market – Revenue Forecast And Analysis – 2019- 2027

Figure 16.        Global Biopharmaceutical Contract Manufacturing Market – By Geography Forecast And Analysis –  2019- 2027

Figure 17.        Market Positioning Of Key Players In Global Biopharmaceutical Contract Manufacturing Market

Figure 18.        Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2019 and 2027)

Figure 19.        Biologics: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Monoclonal Antibodies: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Recombinant Proteins: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Vaccines: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Others: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Biosimilars: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027  (US$ Million)

Figure 25.        Biopharmaceuticals Contract Manufacturing Market, by Service, 2019 and 2027 (%)

Figure 26.        Development Process: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27.        Final Dosage Operation: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)

Figure 28.        Analytical and Quality Control: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29.        Final Packaging: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2027  (US$ Million)

Figure 30.        North America: Biopharmaceutical Contract Manufacturing Market, by Key Country – Revenue (2019) (USD Million)

Figure 31.        North America Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2027 (USD Million)

Figure 32.        North America: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)

Figure 33.        US: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 34.        Canada: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 35.        Projection of the Use of Pharmaceutical Products in Mexico (Million Dollars)

Figure 36.        Mexico: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 37.        Europe: Biopharmaceutical Contract Manufacturing Market, by Key Country – Revenue (2019) (USD Million)

Figure 38.        Europe Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2027 (USD Million)

Figure 39.        Europe: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)

Figure 40.        Germany: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 41.        UK: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 42.        France: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 43.        Spain: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 44.        Italy: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 45.        Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Key Country – Revenue (2019) (USD Million)

Figure 46.        Asia Pacific Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2027 (USD Million)

Figure 47.        Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)

Figure 48.        China: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 49.        Japan: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 50.        India: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 51.        South Korea: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027  (USD Million)

Figure 52.        Australia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 53.        Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Key Country – Revenue (2019) (USD Million)

Figure 54.        Middle East & Africa Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2027  (USD Million)

Figure 55.        Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Share by Country – 2019 & 2027, (%)

Figure 56.        Saudi Arabia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027  (USD Million)

Figure 57.        UAE: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)

Figure 58.        South Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027  (USD Million)

Figure 59.        South and Central America: Biopharmaceutical Contract Manufacturing Market, by Key Country – Revenue (2019) (USD Million)

Figure 60.        South and Central America Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2027 (USD Million)

Figure 61.        South and Central America: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)

Figure 62.        Brazil: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 63.        Argentina: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 64.        IMPACT OF COVID-19 PANDEMIC IN NORTH AMERICAN COUNTRY MARKETS

Figure 65.        IMPACT OF COVID-19 PANDEMIC IN EUROPE COUNTRY MARKETS

Figure 66.        IMPACT OF COVID-19 PANDEMIC IN ASIA-PACIFIC COUNTRY MARKETS

Figure 67.        IMPACT OF COVID-19 PANDEMIC IN REST OF WORLD COUNTRY MARKETS

Figure 68.        Growth Strategies Done by the Companies in the Market, (%)

 

The List of Companies - Biopharmaceuticals Contract Manufacturing Market

 

  1. Lonza Group AG
  2. Boehringer Ingelheim International GmbH.
  3. Inno Biologics Ventures Sdn Bhd
  4. Thermo Fisher Scientific
  5. AbbVie Inc.
  6. WuXi Biologics
  7. General Electric
  8. Samsung Biologics
  9. Merck KGaA
  10. Ajinomoto Co., Inc
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the biopharmaceuticals contract manufacturing market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global biopharmaceuticals contract manufacturing market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00005512
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing